Dynamic modeling and scoring risk assessment

Information

  • Patent Grant
  • 8005690
  • Patent Number
    8,005,690
  • Date Filed
    Wednesday, August 8, 2007
    17 years ago
  • Date Issued
    Tuesday, August 23, 2011
    13 years ago
Abstract
The invention provides for modeling and scoring risk-assessment and a set of insurance products derived therefrom. Risk indicators are determined at a selected time. A population is assessed at that time and afterward for those risk indicators and for consequences associated therewith. Population members are coupled to client devices for determining risk indicators and consequences. A server receives data from each client, and in response thereto and in conjunction with an expert operator, (1) reassesses weights assigned to the risk indicators, (2) determines new risk indicators, (3) determines new measures for determining risk indicators and consequences, and (4) presents treatment options to each population member. The server determines, in response to the data from each client, and possibly other data, a measure of risk for each indicated consequence or for a set of such consequences. The server provides this measure with regard to each population member, or with regard to population subsets. The expert operator uses this measure to determine either (1) an individual course of treatment, (2) a resource utilization review model, (3) a risk-assessment model, or (4) an insurance pricing model, for each individual population member or for selected population subsets. Information requested by the client, information determined and presented by the server, and responsive measurements, are adapted dynamically to changing population aspects or changing population membership, or of an external environment having relevance to the population.
Description
FIELD OF THE INVENTION

The present invention relates generally to computer systems and more particularly to data structures for modeling and scoring risk assessment, such as insurance risk.


BACKGROUND OF THE INVENTION

In the insurance industry and in other fields in which risk is assessed (including such diverse fields as medical treatment, financial modeling and portfolio management, and environmental impact regulation), it is known to develop and use a risk-assessment model of a population. The risk-assessment model provides a technique for determining which population members are more subject or less subject to particular risks (or to an aggregate of risks) than the norm for that population. For example, in life insurance underwriting, it is known to evaluate past and present medical data so as to determine what insurance premium the underwriter wishes to charge.


While these known methods generally achieve the goal of assessing risk for particular individuals in comparison to a population norm, they have the drawback of making a risk assessment that is fixed at a particular point in time. That is, these risk-assessment models rely on static data, in particular (1) static data about the individual population member, (2) static data about the population norm, and (3) static data about risks associated or correlated with the data about the individual population member. However, risk for individual population members depends not only on their present data, but also on their future data, including both data about behavior and environment.


A first type of problem for the known art includes those individuals that have a progressive disease or degenerative condition, in which the disease or condition progresses at a rate that is responsive to behavior or environment of the individual. For such individuals, risk is more accurately evaluated as a function of behavior measured over time and environment measured over time, rather than as a static value that is a function only of present behavior and environment. For example, a first patient with diabetes can proceed with relatively small risk if that first patient is aware of and active in management of behavioral and environmental risk factors. In contrast, an otherwise identical second patient will have significantly greater risk if that second patient is either unaware of, or unable or unwilling to take charge of, behavioral and environmental risk factors.


Related to this first type of problem is the problem of determining trends for individual risk-assessment. For example, an individual with a history of diabetes may suffer a significant increase or decrease in effects thereof, due at least in part to that patient's actions with regard to behavioral and environmental risk factors. Similarly to the first type of problem, that individual will be rationally assessed a significantly greater or lesser risk than originally, if the new facts were known to the underwriter. Such trends may differ significantly from any trends that might have been discerned from past medical history alone; such trends may also themselves involve genetic, environmental, or behavioral components, or some combination thereof.


A second type of problem for the known art includes individuals whose risk-assessment significantly changes due to the vicissitudes of their life trajectory. This can include progression of a disease or condition, responsive at least in part to behavioral or environmental factors. For a more striking example, an individual may suffer a myocardial infarction, or become infected with an HIV variant. Similarly to the first type of problem, that individual would be rationally assessed a significantly greater risk than originally, if the new facts were known to the underwriter. Alternatively, an individual may be successfully treated for a “curable” disease such as Hodgkin's disease or some forms of cancer. Such vicissitudes of life trajectory may themselves involve genetic, environmental, or behavioral components, or some combination thereof.


A third type of problem for the known art includes individuals who significantly change their behavior or environment, particularly when those individuals are susceptible to the elements of their behavior or environment they change. For example, an individual with diabetes can determine to alter their diet favorably or unfavorably. For a more striking example, an individual may take up smoking or skydiving as habits. That individual will become a significantly greater risk than the underwriter originally assessed.


Moreover, new medical research may indicate risk factors that were not known at the time risk for the individual was originally assessed. These could include past medical information not known at the time to be important, tests available in the future for risk factors not known at the time at all, or changes in the medical history of the individual that place that individual in different risk factor categories. Such past medical information or risk factors may themselves involve genetic, environmental, or behavioral elements, or some combination thereof.


Accordingly, it would be advantageous to collect feedback from individual population members, whether on a periodic or aperiodic basis, and whether prompted by selected events or not. Such feedback would allow underwriters or other risk-assessment or risk-management personnel to determine specific risk-related information about each individual population member, and to adjust (such as to make more accurate or precise) insurance models and risk-assessment models to fit the new data. Such feedback enables the advantage of providing information about the time-varying nature of individual measures which can be used in the dynamic risk assessment model presented in the present invention. For instance, a weight gain of 10 pounds per year, an increase in diastolic blood pressure of 10 points per year, and an increase of cholesterol of 10 points per year could be tracked over time and would yield health risk information.


To achieve this advantage, a first aspect of the invention is that feedback is collected by a client-server system in which data is requested or required from population members. A server device, responsive to a risk-assessment model, prompts a client device supplied to population members to request information from population members, in order to determine whether aggregate measures or individual measures of risk-assessment remain in coherence with the model. The client device collects the data and supplies it to the server device, which can, in response to dynamically collected data, adjust the model, adjust risk assessments for selected population members (or groups thereof), or determine further information to collect from population members.


Upon achieving this advantage, a second aspect of the invention is to provide a set of superior risk-assessment models and insurance models in response to the feedback. These superior risk-assessment models and insurance models can include information about the risk-related behavior, risk-related trends, or forward-looking risk-assessment of selected individuals or selected subsets of the population. These superior risk-assessment models and insurance models can be responsive to data-mining techniques described in related patent applications, described below, hereby incorporated by reference as if fully set forth herein. These superior risk-assessment models can also incorporate known scientific information regarding health risk or disease progression, such as well-determined correlations of risk factors and disease incidence or progression from large research studies, or well-known shape of 5-year survival curves for patients having specific types of cancer.


Accordingly, it would also be advantageous to provide a set of techniques for modeling and scoring risk-assessment and a set of insurance products derived therefrom, using dynamic assessment of risk indicators and associated consequences for a population. This advantage is achieved in an embodiment of the invention in which a population (such as a population of medical patients) is assessed both at a selected time and afterward for those risk indicators and for consequences associated therewith. A client-server system provides dynamic data collection and analysis, dynamic risk assessment in response to that data collection and analysis, and dynamic treatment options and utilization review for each population member.


SUMMARY OF THE INVENTION

The invention provides a set of techniques for modeling and scoring risk-assessment and a set of insurance products derived therefrom. A set of risk indicators (such as medical risk factors for individuals) is determined at a selected time. A population (such as a population of medical patients) is assessed at the selected time and afterward for those risk indicators and for consequences associated therewith. For example, the population can be periodically assessed for correlation between smoking and heart disease, for correlation between alcohol use and heart disease, and for multivariate correlation of a plurality of such indicators and consequences.


In a preferred embodiment, selected population members are each coupled to client devices for determining risk indicators and consequences. For example, where the population is a set of medical patients, the client device can include a local device for asking medical, psychological and life-style questions, and for measurement of medical parameters, for each of those patients. A server device receives data from each client device, and in response thereto, can (1) reassess weights assigned to the risk indicators, (2) determine new significant risk indicators, (3) determine new significant measures for determining risk indicators and consequences, and (4) present treatment options to each population, member. The server device can perform these tasks in conjunction with an operator, such as a skilled medical professional, risk-management assessor, or other expert.


The server device can determine, in response to the data from each client device, and possibly in response to other data (such as provided by the expert operator), a measure of risk for each indicated consequence or for a set of such consequences. The server device can provide this measure with regard to each population member, or with regard to population subsets (selected either with regard to the known risk indicators or other indicators). The expert operator can use this measure to determine either (1) an individual course of treatment, (2) a resource utilization review model, (3) a risk-assessment model, or (4) an insurance pricing model, for each individual population member or for selected population subsets.


In a preferred embodiment, information requested by the client device, information determined and presented by the server device, and measurements determined in response thereto, can be adapted dynamically to changing aspects or changing membership of the population, or of an external environment having relevance to the population. For example, medical treatment or risk-assessment models can be dynamically adapted to an aging population or to biomedical advances with regard to detection or treatment of medical conditions for members of that population.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1
a shows a block diagram of a system for data collection and interpretation for a population. FIG. 1b shows details of the client device 110 shown in FIG. 1a. FIG. 1c shows devices that may be connected to client device 110. FIG. 1d shows details of the data review device.



FIG. 2 shows a response diagram of consequences to risk indicators, for statistical aggregates of the population, which can be selected in response to dynamic data collection and analysis.



FIG. 3
a shows a process flow diagram of a method for dynamic data collection to be performed by the system; verification of model, updating a model, or creating a new model, and re-evaluation of risk assessment. FIG. 3b shows a process flow diagram of the step of dynamic data collection. FIG. 3c shows a process flow diagram of the step of verification of the model. FIG. 3d shows a process flow diagram of the step of updating the existing model.



FIG. 4
a shows a process flow diagram of a method for dynamic data analysis to be performed by the system. FIG. 4b shows a process flow diagram for data mining.



FIG. 5 shows a response diagram of consequences to risk indicators, for statistical aggregates of the population, with data collected from an individual at different points of time also plotted.



FIG. 6 shows a process flow diagram for a method of providing treatment options and information to each patient based on the data provided to the server.





DESCRIPTION

In the following description, a preferred embodiment of the invention is described with regard to preferred process steps and data structures. Embodiments of the invention can be implemented using general purpose processors or special purpose processors operating under program control, or other circuits, adapted to particular process steps and data structures described herein. Implementation of the process steps and data structures described herein would not require-undue experimentation or further invention.


System for Data Collection



FIG. 1
a shows a block diagram of a system for data collection and interpretation for a population. Referring to FIG. 1a, a system 100 includes a client device 110, a server device 120 including a program memory 122 and database of patient information 121, and a data review element 130. These devices are connected via a communication channel, such as a communication network as in known in the art and more fully described in the Phenoscope and Phenobase patent (U.S. Ser. No. 09/041,809) and related patent application Ser. No. 08/946,341 and other patents and patent applications previously incorporated by reference.


Referring to FIG. 1b, the client device 110 is disposed locally to a patient 111, and includes an output element 112 for presenting information to the patient 111, and an input element 113 for entering information from the patient 111. As used herein, “locally” refers to a logical relationship to the patient 111, and does not have any necessary implication with regard to actual physical position. In a preferred embodiment, the client device 110 is relatively small or compact, and can be disposed on a night table or otherwise near the patient 111.


The output element 112 includes a display screen 114, on which questions and suggested answers can be displayed for the patient 111, so as to facilitate information entry, or on which instructions can be displayed for the patient 111, so as to instruct the patient 111. The output element 112 can also include a speaker 115, so as to present information in conjunction with or in alternative to the display screen 114. The output element 112 can also include a bell or other sound element, or a bright light 119 or a flag, so as to alert the patient 111 that the client device 110 has questions or information for the patient 111.


The input element 113 includes a plurality of buttons 116A-D for entering information, preferably such as described in the patent applications referenced and incorporated by reference above.


The input element 113 can also include one or more data ports 117A-D for entering information from other devices. Referring to FIG. 1c, such other devices I 18 can include a medical measurement device, such as a blood glucose meter or a blood pressure monitor. Such other devices 118 can include a dispensing device for medication.


Such other devices 118 can also include a general purpose or special purpose client workstation, such as a personal computer or a hand-held digital calendar.


The server device 120 is disposed logically remotely from the patient 111, and includes a database 121 of information about the patient 111 and about other patients in a related population thereof. As used herein, “remotely” refers to a logical relationship to the patient 111, and does not have any necessary implication with regard to actual physical position.


The server 120 and patient profile database 121 are preferably accessible by means of a standard network connection such as a world wide web connection. Server 120 and database 121 may comprise single stand-alone computers or multiple computers distributed throughout a network.


Referring to FIG. 1a and FIG. 1d, the data review element 130 is disposed logically remotely from the patient 111, and includes an interface 131 disposed for use by an operator 132. The operator 132 can comprise medical personnel, a device operated by medical personnel, or a similar device, capable of interacting with the interface 131 so as to receive information from the data review element 130 and possibly to enter information into the data review element 130. Information entered into the data review element 130 can be entered for ultimate transmission to the server device 120 or to the client device 110.


The data review element 130 is preferably a personal computer, remote terminal, web TV unit, Palm Pilot unit, interactive voice response system, or any other communication technique. The data review element functions as a remote interlace for entering in server 120 or client device 110 messages and queries to be communicated to the individuals.


Aggregate Responses to Risk Indicators



FIG. 2 shows a response diagram 200a of consequences to risk indicators, for statistical aggregates of the population, which can be selected in response to dynamic data collection and analysis. It is to be noted that FIG. 2 shows curves that are collapsed to 2-dimensions, in a preferred embodiment the curves are N-dimensional, with N>2.


A diagram 200a includes a first axis X 201 and a second axis Y 202. The diagram shows a first response curve RO 210 showing a normal trajectory for vital function and life expectancy of an individual or subpopulation of the population. The first axis X 201 indicates a relative time, as measured toward a right side of the diagram. The scale of the first axis X 201 is a relative time whose initial left hand point may be undetermined. As to a first response curve RO 210, the second axis Y 202 represents a measure of vital function and life expectancy.


A diagram 200a also shows a second response curve SO 220 showing a normal trajectory for a measure of expected medical expense or risk for an individual or subpopulation of the population. The first axis X 201 indicates a relative time as for a first response curve RO 210. As to a second response curve SO 220, the second axis Y 202 shows increasing expense or risk as measured toward the top of the diagram.


In the first response curve RO 210, the normal trajectory for vital function and life expectancy for a typical individual in the population shows that as time progresses, vitality and life expectancy are expected to decrease. This general concept is known in the art of actuaries. It is to be noted that the shape shown by the first response curve RO 210 is an example shape; for instance, it is known that for certain curable cancers, risk increases, then levels off after a certain length of time such as a 5-year survival rate, then later in life risk increases due to other causes.


The first response curve RO 210 includes a number of points with error bars 211 about the response curve RO 210. All of the points 211 are at an identical value, VO, of the second axis Y 202, with identical error bars. Any one of the points represents a single measurement of vitality taken for an individual. Given any single measurement of vitality, it is difficult to determine where along the second axis X 201, that is, where along the trajectory the individual is. Of particular interest is how close to a rapid decline in vitality or increase in risk the individual is. The points 211 show the several places along the curve where the individual might be placed, based on this single measurement of vitality. Because the response curve RO 210 is slowly varying through much of the time, that is, the values of vitality and life expectancy clustering in a selected region of the second axis Y 202, shown by the bracket 203, and due to margins of error in both the measurement as well as the response curve, there are several positions along the curve where an individual with a specific measurement might be; these several positions are shown by points 211.


By contrast, if measurements are taken for an individual at more than one point in time, greater information is present, and in particular trends may be discerned which yield more information about where on the curve an individual is. This ability to discern trends is greater when curves in N-dimensions are considered. For instance, an individual whose excess weight has slowly climbed in conjunction with slowly increasing cholesterol, blood pressure, stress levels and family medical history would be placed in a greater risk category although the individual measures of, for instance, cholesterol, might be within a normal range.


Similarly, in the second response curve SO 220, the normal trajectory for expected medical expense and risk for that typical individual shows that as time progresses, expected medical expense and risk are expected to increase. This general concept is also known in the art of actuaries. It is to be noted that the shape shown by the second response curve RO 220 is an example shape; for instance, upon diagnosis of a disease the expense may climb, but if the patient is cured the expense will level off.


Similarly, the second response curve SO 220 includes a number of points 221 on the response curve SO 220, showing possible places that an individual in the population with measurement of expense or risk, with value E0, might be. Because most of the values of response curve SO 220 cluster in a selected region of the second axis Y 202 shown by the bracket 204, it is difficult to know where along curve SO 220 an individual with measurement E0 should be placed. This is due to both possible error in measurement of E0 as well as uncertainty in the exact “true” position and shape of curve SO 220. As for curve RO 210, measurements of expense or risk taken over time will yield useful information about where on the curve SO 220 an individual is.


When subsets of the population are selected in response to specific risk factors, the statistical aggregates of the population can differ substantially from the aggregate response curves RO 210 and SO 220 for the entire population. The diagram 200a shows response curves R1a 212 and R1b 213 showing a normal life trajectory for vital function and life expectancy of an “average” individual in the population, depending on whether that individual is associated with a selected risk factor a. As with regard to the aggregate for the entire population, it is difficult to determine from a specific single measurement just where on either response curve R1a 212 or R1b 213 the individual should be assessed. Depending on whether the value of a is known for an individual, it may also be difficult to know whether the individual should be placed on response curve R1a 212 or R1b 213. Measurements of several risk indicators taken over time may yield information on whether a specific individual should be placed in category R1a 213 or the higher risk category R1b 212. The general concept of using time-dependent information to determine risk along is also illustrated in FIG. 5.


The client device 110 determines information from which the server device 120 or the data review element 130 can analyze the time varying nature of data. The server device 120 or the data review element 130 can therefore determine both of the following: (1) just where on either response curve R1a 212 or R1b 213 the individual should be assessed; and (2) whether the individual should be assessed on the response curve R1a 212 or the response curve R1b 213.


It is to be noted that the above analysis has been condensed to 2-dimensions for convenience in presentation, with a single measurement along a single X-axis or Y-axis. In a preferred embodiment, a measurement would have many attributes, i.e. the model would have N-dimensions, and more sophisticated techniques for analyzing trends and achieving objectives are used.


If the data for the population is not known for all individuals in the population or subpopulation of interest, the server device 120 transmits a new set of information-gathering instructions (such as questions and suggested answers) to the client device 110, so as to measure that information individually for each patient 111.


Dynamic Modeling and Risk Evaluation



FIG. 3
a shows a process flow diagram 300a for a method with steps of dynamically collecting information 310, choosing to verify or update the model or to create new model 320, verifying 350 or updating 330 the risk assessment model or creating a new model 340, deciding whether to re-evaluate risk 360 and re-evaluating risk based on updated information and current model 370.


Dynamic Data Collection for Population



FIG. 3
b shows a process flow diagram 300b of a method for dynamic data collection to be performed by the system. This data collection may be done periodically or aperiodically, upon a triggering event or decision by the expert operator. The population or subpopulation from which to collect data is selected 380. The selection criteria may be based on preset values or may be set by the expert operator. The set of risk indicators or other information to be collected is selected 382, based either on preset values or decision by the expert operator. The individuals in the subpopulation of interest are queried 384 as to the information of interest and the database is updated 386. “The pre-query steps need not be done in the order indicated.


Verification of Existing Model and Update of Model



FIG. 3
c shows a process flow diagram 300c of a method by which the updated data can be analyzed to determine whether the existing model is consistent with the updated data; that is, to verify that the data conforms to the model within acceptable variation or error. This is accomplished by putting the updated data into categories 390, determining the updating measures of life vitality or costs 392, determining the values predicted by the model 394, comparing the updated measures of life vitality or costs against those predicted by the model 396. and determining whether the comparison is acceptable 397. If the predicted value is within an acceptable distance from the updated values based on well known measures such as statistical error, then the model need not be adjusted. The expert operator may also visually determine whether the updated data and existing model show an acceptable relationship to each other.



FIG. 3
d shows a process flow diagram 300d of a method for updating the existing risk model in response to updated information. By updating, it is meant that no new risk indicators are added, and no new external constraints on the model are added. The risk model to be adjusted may be for the aggregate population or for various subpopulations. The updated information for the subpopulation is categorized 398 according to profile information into one or more existing categories. The subpopulation is categorized according to one or more existing measure of life vitality or medical expense. Statistical analyses as described below or in other patents or patent applications previously incorporated by reference or as known in the art of statistics are applied to determine updated values for model parameters such as weights to give each factor 399


Re-Evaluating Risk Assessment Based on Updated Information


As shown in FIG. 3a, a current model can be determined based on updated information. Once a current model is determined, which may include simply using the already existing model, individual or subpopulation risk assessment may be reevaluated in response to one or more pieces of updated information, as desired by the expert operator or as a preprogrammed operation.


Dynamic Data Analysis for Population



FIG. 4
a shows a process flow diagram 400a of a method for dynamic data analysis (“data mining”) to be performed by the system. The updated database can be mined to create a new model that may include reassessment of weights assigned to the risk indicators, addition of new significant risk indicators, or determination of new significant measures for determining risk indicators and consequences. Applied examples of data mining and additional explanation are shown in the related application Ser. No. 09/041,809 and other applications referenced above.



FIG. 4
b shows a process flow diagram of a method of using the statistical method of calculating correlations on subpopulations, following the steps of: (1) choose a risk factor 450; (2) divide the risk pool into two groups based on outcome 460; (3) search all other data for correlation to high versus low risk 470; (3) create a new risk factor based on this correlation 480. The new risk factor may be a discrete piece of data that was asked of the client but was not previously known to be a significant predictor, or it may be a new factor that is generated by combining other pieces of data. FIG. 4b is a process flow diagram of the above steps.


In addition to data mined from the database, in creating a new model, scientific information well known in the literature may supplement the data. For instance, scientific information regarding certain well studied correlations be considered such as known correlations of time since quitting smoking and various health conditions, known information regarding the shape of life expectancy curves for certain types of cancer patients, or recent information regarding efficacy of new forms of treatment for diseases such as recent significant improvements in treatment of AIDS.


Statistical analyses are known in the art of statistics, and include correlation analyses, multivariate regressions, constrained multivariate regressions, or variance analyses, may also be run on the data to reveal statistical relationships among the various information or measures of life vitality or medical expense in order to improve the predictive power of a model, although in a preferred embodiment data mining is done as presented in the preceding paragraphs.


Modeling and Scoring Risk Assessment, Insurance Pricing


Modeling risk is performed by assigning risk to individual in response to risk factors identified for that individual, and such modeling may be done for the population or for a subpopulation. There are many techniques for modeling, such as linearly risk scoring by assigning a number to each risk factor and adding up each number to determine a total risk score, non-linearly assessing risk by combining risk factors non-linearly to determine risk which may be achieved by neural network techniques which are known in the art of neural networks, or other techniques.



FIG. 5 shows a diagram 500 including a first axis X 502 and a second axis Y 503 and a response curve RO 501, similar to that shown in FIG. 2. It shows several measurements of vitality with error bars 511 of an individual taken at several different points in time. Each measurement of vitality is taken at a later time from left to right. Information about the time varying nature of the measurements, or the trends, can improve the ability to predict future vitality, including imminent sharp declines in vitality, as can been seen by visually examining the data over time or by using sophisticated statistical techniques to examine the data and trends in the data over N-dimensions.


Insurance pricing may be achieved from advantages in risk assessment. It is known in the art of actuarial analysis to assign price in response to risk.


Providing Treatment Options and Information to each Population Member



FIG. 6 is a process flow diagram 600 showing a method for providing treatment options and information to each member based on the information provided. Upon receiving information about the patient from the client 610, the server or expert operator may identify a risk group 620 and identify an appropriate medical protocol 630, the server may present one or more responses to the patient 640, including treatment options, advice or merely health information that would be useful to the patient, and the client device may be configured to use an appropriate medical protocol in interacting with the patient 650. It is known in the art of medicine that membership in a risk group may indicate appropriate treatment. This may be done from an automated, preset set of responses to individual queries made to the patient, on an aggregate of preset responses to queries, or by an expert operator.


ALTERNATIVE EMBODIMENTS

Although preferred embodiments are disclosed herein, many variations are possible which remain within the concept, scope, and spirit of the invention, and these variations would become clear to those skilled in the art after perusal of this application.

Claims
  • 1. A system for determining compliance with a regimen, comprising: a client device associated with each individual of a group, the client device configured for acquiring a first set of data from each individual of the group and a second set of data from each individual of the group, said client device including a display, an input device for receiving information, an output device configured to alert an individual that information is requested from the individual and a data port, the second set of data being acquired after a time period has elapsed after acquisition of the first set of data;a medical measurement device coupled to said data port of said client device, the medical measurement device configured for obtaining measurement data from each individual of the group, the medical measurement device including at least one of a blood glucose meter, blood pressure monitor and medication dispensing device, the client device configured for receiving the measurement data and for integrating said measurement data within said first set of data and said second set of data; anda server device, the server device operably connected to the client device associated with each individual of a group via a communication pathway, the server device configured for analyzing the first set of data and the second set of data to assess a change for the group by comparing the second set of data to the first set of data after performing a regimen, said regimen including a prescribed diet, exercise and medication, wherein an award is distributed to the group based upon the change.
  • 2. The system as claimed in claim 1, wherein the client device prompts each individual of the group to enter the first set of data and the second set of data into the client device.
  • 3. The system as claimed in claim 1, wherein the communication pathway is established between the client device and the server device by at least one of an internet connection, an intranet connection, a local area network, a telephone connection, a wireless connection, a cable connection, a satellite connection, a router connection, an Ethernet connection, a serial connection, a USB connection, a firewire connection, a microwave connection and a cellular connection.
  • 4. The system as claimed in claim 1, wherein the award is distributed to the group for improvement in a measure of a health condition.
  • 5. The system as claimed in claim 1, wherein the award is at least one of a reduction in an insurance premium, a pecuniary benefit, an expansion of insurance coverage, a bonus, an incentive, and a continuance of insurance coverage.
  • 6. The system as claimed in claim 1, wherein said output device of said client device includes an audio element and video element.
  • 7. The system as claimed in claim 1, wherein said audio element is a speaker.
  • 8. The system as claimed in claim 1, wherein said output device of said client device is configured to alert said individual that information is requested from the individual according to a periodic schedule.
  • 9. The system as claimed in claim 1, wherein said output device of said client device is configured to alert said individual that information is requested from the individual according to an aperiodic schedule.
  • 10. The system as claimed in claim 1, wherein said output device of said client device is configured to alert said individual that information is requested from the individual after a triggering event.
CROSS REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 09/625,080 filed Jul. 25, 2000, now U.S. Pat. No. 7,305,348 which is a continuation of U.S. patent application Ser. No. 09/160,970 filed Sep. 25, 1998, issued as U.S. Pat. No. 6,240,393. Said U.S. patent application Ser. No. 09/625,080 and U.S. patent application Ser. No. 09/160,970 are hereby incorporated by reference in their entirety. The following applications are hereby incorporated by reference: U.S. patent application Ser. No. 09/159,219 filed Sep. 23, 1998 (abandoned) U.S. patent application Ser. No. 09/159,058 filed Sep. 23, 1998 (abandoned)

US Referenced Citations (388)
Number Name Date Kind
3426150 Tygart Feb 1969 A
3566365 Rawson et al. Feb 1971 A
3566370 Worthington, Jr. et al. Feb 1971 A
3581072 Nymeyer May 1971 A
3768014 Smith Oct 1973 A
3811116 Takeuchi et al. May 1974 A
3883235 Lynn et al. May 1975 A
3910257 Fletcher et al. Oct 1975 A
3920005 Gombrich et al. Nov 1975 A
3996928 Marx Dec 1976 A
4004577 Sarnoff Jan 1977 A
4051522 Healy et al. Sep 1977 A
4060915 Conway Dec 1977 A
4130881 Haessler et al. Dec 1978 A
4150284 Trenkler et al. Apr 1979 A
4151407 McBride et al. Apr 1979 A
4151831 Lester May 1979 A
4173971 Karz Nov 1979 A
4216462 McGrath et al. Aug 1980 A
4227526 Goss Oct 1980 A
4253521 Savage Mar 1981 A
4259548 Fahey et al. Mar 1981 A
4270547 Steffen et al. Jun 1981 A
4296756 Dunning et al. Oct 1981 A
4347568 Giguere et al. Aug 1982 A
4347851 Jundanian Sep 1982 A
4360345 Hon Nov 1982 A
4412287 Braddock, III Oct 1983 A
4417306 Citron et al. Nov 1983 A
4422081 Woods Dec 1983 A
4428733 Kumar-Misir Jan 1984 A
4449536 Weaver May 1984 A
4465077 Schneider Aug 1984 A
4473884 Behl Sep 1984 A
4518361 Conway May 1985 A
4519398 Lisiecki et al. May 1985 A
4531527 Reinhold, Jr. Jul 1985 A
4546436 Schneider et al. Oct 1985 A
4566461 Lubell et al. Jan 1986 A
4576578 Parker et al. Mar 1986 A
4592546 Fascenda et al. Jun 1986 A
4627445 Garcia Dec 1986 A
4674652 Aten et al. Jun 1987 A
4686624 Blum et al. Aug 1987 A
4694490 Harvey et al. Sep 1987 A
4695954 Rose et al. Sep 1987 A
4712562 Ohayon et al. Dec 1987 A
4722349 Baumberg Feb 1988 A
4729381 Harada et al. Mar 1988 A
4730253 Gordon Mar 1988 A
4731726 Allen, III Mar 1988 A
4738451 Logg Apr 1988 A
4768229 Benjamin et al. Aug 1988 A
4779199 Yoneda et al. Oct 1988 A
4782511 Nemec et al. Nov 1988 A
4789928 Fujisaki Dec 1988 A
4796639 Snow et al. Jan 1989 A
4799156 Shavit et al. Jan 1989 A
4799199 Scales, III et al. Jan 1989 A
4803625 Fu et al. Feb 1989 A
4835372 Gombrich et al. May 1989 A
4838275 Lee Jun 1989 A
4846797 Howson et al. Jul 1989 A
4853521 Claeys et al. Aug 1989 A
4858354 Gettler Aug 1989 A
4858617 Sanders Aug 1989 A
4890621 Hakky Jan 1990 A
4894777 Negishi et al. Jan 1990 A
4897869 Takahashi Jan 1990 A
4899839 Dessertine et al. Feb 1990 A
4903201 Wagner Feb 1990 A
4907973 Hon Mar 1990 A
4931934 Snyder Jun 1990 A
4933873 Kaufman et al. Jun 1990 A
4933876 Markoff et al. Jun 1990 A
4950246 Muller Aug 1990 A
4950264 Osborn, III Aug 1990 A
4953552 DeMarzo Sep 1990 A
4958632 Duggan Sep 1990 A
4958641 Digby et al. Sep 1990 A
4967756 Hewitt Nov 1990 A
4977899 Digby et al. Dec 1990 A
4978303 Lampbell Dec 1990 A
4978335 Arthur, III Dec 1990 A
4979509 Hakky Dec 1990 A
5007429 Treatch et al. Apr 1991 A
5009645 Silver et al. Apr 1991 A
5016172 Dessertine May 1991 A
5019974 Beckers May 1991 A
5024225 Fang Jun 1991 A
5025374 Roizen et al. Jun 1991 A
5034807 Von Kohorn Jul 1991 A
5035625 Munson et al. Jul 1991 A
5036462 Kaufman et al. Jul 1991 A
5049487 Phillips et al. Sep 1991 A
5050612 Matsumura Sep 1991 A
5056059 Tivig et al. Oct 1991 A
5059394 Phillips et al. Oct 1991 A
5065315 Garcia Nov 1991 A
5068536 Rosenthal Nov 1991 A
5074317 Bondell et al. Dec 1991 A
5077476 Rosenthal Dec 1991 A
5077665 Silverman et al. Dec 1991 A
5095798 Okada et al. Mar 1992 A
5104380 Holman et al. Apr 1992 A
5109414 Harvey et al. Apr 1992 A
5109974 Beer et al. May 1992 A
5111396 Mills et al. May 1992 A
5111817 Clark et al. May 1992 A
5111818 Suzuki et al. May 1992 A
5120230 Clark et al. Jun 1992 A
5120421 Glass et al. Jun 1992 A
5128752 Von Kohorn Jul 1992 A
5134391 Okada Jul 1992 A
5142358 Jason Aug 1992 A
5142484 Kaufman et al. Aug 1992 A
5143378 Joel Sep 1992 A
5171977 Morrison Dec 1992 A
5176502 Sanderson et al. Jan 1993 A
5182707 Cooper et al. Jan 1993 A
5204670 Stinton Apr 1993 A
5219322 Weathers Jun 1993 A
5222020 Takeda Jun 1993 A
5226895 Harris Jul 1993 A
5227874 Von Kohorn Jul 1993 A
5228450 Sellers Jul 1993 A
5230629 Buschke Jul 1993 A
5231990 Gauglitz Aug 1993 A
5243515 Lee Sep 1993 A
5249044 Von Kohorn Sep 1993 A
5251126 Kahn et al. Oct 1993 A
5261401 Baker et al. Nov 1993 A
5262943 Thibado et al. Nov 1993 A
5265888 Yamamoto et al. Nov 1993 A
5266179 Nankai et al. Nov 1993 A
5275159 Griebel Jan 1994 A
5282950 Dietze et al. Feb 1994 A
5295491 Gevins Mar 1994 A
5299121 Brill et al. Mar 1994 A
5301105 Cummings, Jr. Apr 1994 A
5304112 Mrklas et al. Apr 1994 A
5304468 Phillips et al. Apr 1994 A
5307263 Brown Apr 1994 A
5309919 Snell et al. May 1994 A
5321009 Baeder et al. Jun 1994 A
5325288 Satou Jun 1994 A
5329459 Kaufman et al. Jul 1994 A
5329608 Bocchieri et al. Jul 1994 A
5331549 Crawford, Jr. Jul 1994 A
5333981 Pronovost et al. Aug 1994 A
5335338 Proesel Aug 1994 A
5339821 Fujimoto Aug 1994 A
5341291 Roizen et al. Aug 1994 A
5343239 Lappington et al. Aug 1994 A
5344324 O'Donnell et al. Sep 1994 A
5357427 Langen et al. Oct 1994 A
5366896 Margrey et al. Nov 1994 A
5368562 Blomquist et al. Nov 1994 A
5371687 Holmes, II et al. Dec 1994 A
5375604 Kelly et al. Dec 1994 A
5377100 Pope et al. Dec 1994 A
5390238 Kirk et al. Feb 1995 A
5399821 Inagaki et al. Mar 1995 A
5410471 Alyfuku et al. Apr 1995 A
5410474 Fox Apr 1995 A
5429140 Burdea et al. Jul 1995 A
5431690 Schaldach et al. Jul 1995 A
5431691 Snell et al. Jul 1995 A
5434611 Tamura Jul 1995 A
5438607 Przygoda, Jr. et al. Aug 1995 A
5438983 Falcon Aug 1995 A
5441047 David et al. Aug 1995 A
5449334 Kingsbury Sep 1995 A
5454721 Kuch Oct 1995 A
5454722 Holland et al. Oct 1995 A
5456606 McIntyre Oct 1995 A
5456692 Smith, Jr. et al. Oct 1995 A
5458123 Unger Oct 1995 A
5467269 Flaten Nov 1995 A
5471039 Irwin, Jr. et al. Nov 1995 A
5471382 Tallman et al. Nov 1995 A
5483276 Brooks et al. Jan 1996 A
5488412 Majeti et al. Jan 1996 A
5488423 Walkingshaw et al. Jan 1996 A
5501231 Kaish Mar 1996 A
5502636 Clarke Mar 1996 A
5502726 Fischer Mar 1996 A
5504519 Remillard Apr 1996 A
5517405 McAndrew et al. May 1996 A
5518001 Snell May 1996 A
5519058 Gonick et al. May 1996 A
5519433 Lappington et al. May 1996 A
5523232 Sechler Jun 1996 A
5536249 Castellano et al. Jul 1996 A
5542420 Goldman et al. Aug 1996 A
5544649 David et al. Aug 1996 A
5546943 Gould Aug 1996 A
5549117 Tacklind et al. Aug 1996 A
5550575 West et al. Aug 1996 A
5553609 Chen et al. Sep 1996 A
5558638 Evers et al. Sep 1996 A
5564429 Bornn et al. Oct 1996 A
5569212 Brown Oct 1996 A
5572421 Altman et al. Nov 1996 A
5572646 Kawai et al. Nov 1996 A
5574828 Hayward et al. Nov 1996 A
5576952 Stutman et al. Nov 1996 A
5583758 McIlroy et al. Dec 1996 A
5590648 Mitchell et al. Jan 1997 A
5593349 Miguel et al. Jan 1997 A
5593390 Castellano et al. Jan 1997 A
5594637 Eisenberg et al. Jan 1997 A
5596994 Bro Jan 1997 A
5597307 Redford et al. Jan 1997 A
5601435 Quy Feb 1997 A
5613495 Mills et al. Mar 1997 A
5619991 Sloane Apr 1997 A
5624265 Redford et al. Apr 1997 A
5628309 Brown May 1997 A
5629981 Nerlikar May 1997 A
5631844 Margrey et al. May 1997 A
5633910 Cohen May 1997 A
5635532 Samid Jun 1997 A
5639471 Chait et al. Jun 1997 A
5640569 Miller et al. Jun 1997 A
5640953 Bishop et al. Jun 1997 A
5642731 Kehr Jul 1997 A
5642936 Evans Jul 1997 A
5651363 Kaufman et al. Jul 1997 A
5651775 Walker et al. Jul 1997 A
5659691 Durward et al. Aug 1997 A
5666487 Goodman et al. Sep 1997 A
5670711 Detournay et al. Sep 1997 A
5675635 Vos et al. Oct 1997 A
5678562 Sellers Oct 1997 A
5678571 Brown Oct 1997 A
5679075 Forrest et al. Oct 1997 A
5680590 Parti Oct 1997 A
5680866 Kangas et al. Oct 1997 A
5687322 Deaton et al. Nov 1997 A
5687717 Halpern et al. Nov 1997 A
5687734 Dempsey et al. Nov 1997 A
5689652 Lupien et al. Nov 1997 A
5692906 Corder Dec 1997 A
5704364 Saltzstein et al. Jan 1998 A
5704366 Tacklind et al. Jan 1998 A
5704902 Vandenbelt et al. Jan 1998 A
5704922 Brown Jan 1998 A
5710178 Samid Jan 1998 A
5710918 Lagarde et al. Jan 1998 A
5711297 Iliff Jan 1998 A
5714319 Joutel et al. Feb 1998 A
5715451 Marlin Feb 1998 A
5715823 Wood et al. Feb 1998 A
5717739 Dyer et al. Feb 1998 A
5717913 Driscoll Feb 1998 A
5720733 Brown Feb 1998 A
5722418 Bro Mar 1998 A
5727153 Powell Mar 1998 A
5730124 Yamauchi Mar 1998 A
5730654 Brown Mar 1998 A
5732696 Rapoport et al. Mar 1998 A
5732709 Tacklind et al. Mar 1998 A
5734413 Lappington et al. Mar 1998 A
5749083 Koda et al. May 1998 A
5752234 Withers May 1998 A
5754740 Fukuoka et al. May 1998 A
5760771 Blonder et al. Jun 1998 A
5772585 Lavin et al. Jun 1998 A
5778882 Raymond et al. Jul 1998 A
5782814 Brown et al. Jul 1998 A
5785650 Akasaka et al. Jul 1998 A
5787295 Nakao Jul 1998 A
5791342 Woodard Aug 1998 A
5792117 Brown Aug 1998 A
5793969 Kamentsky et al. Aug 1998 A
5794219 Brown Aug 1998 A
5794251 Watanabe et al. Aug 1998 A
5796393 MacNaughton et al. Aug 1998 A
5799318 Cardinal et al. Aug 1998 A
5800458 Wingrove Sep 1998 A
5802494 Kuno Sep 1998 A
5802534 Hatayama et al. Sep 1998 A
5806057 Gormley et al. Sep 1998 A
5807336 Russo et al. Sep 1998 A
5810747 Brudny et al. Sep 1998 A
5819735 Mansfield et al. Oct 1998 A
5822544 Chaco et al. Oct 1998 A
5822715 Worthington et al. Oct 1998 A
5825283 Camhi Oct 1998 A
5827180 Goodman Oct 1998 A
5828943 Brown Oct 1998 A
5832448 Brown Nov 1998 A
5835896 Fisher et al. Nov 1998 A
5840020 Heinonen et al. Nov 1998 A
5842976 Williamson Dec 1998 A
5868669 Iliff Feb 1999 A
5868683 Protopapas et al. Feb 1999 A
5875432 Sehr Feb 1999 A
5879163 Brown et al. Mar 1999 A
5882338 Gray Mar 1999 A
5887133 Brown et al. Mar 1999 A
5893077 Griffin Apr 1999 A
5893098 Peters et al. Apr 1999 A
5897493 Brown Apr 1999 A
5899855 Brown May 1999 A
5911687 Sato et al. Jun 1999 A
5913310 Brown Jun 1999 A
5913826 Blank Jun 1999 A
5918603 Brown Jul 1999 A
5920477 Hofberg et al. Jul 1999 A
5933136 Brown Aug 1999 A
5935060 Iliff Aug 1999 A
5937387 Summerell et al. Aug 1999 A
5940801 Brown Aug 1999 A
5940802 Hildebrand et al. Aug 1999 A
5941829 Saltzstein et al. Aug 1999 A
5945651 Chorosinski et al. Aug 1999 A
5951300 Brown Sep 1999 A
5954641 Kehr et al. Sep 1999 A
5956501 Brown Sep 1999 A
5960403 Brown Sep 1999 A
5961446 Beller et al. Oct 1999 A
5966526 Yokoi Oct 1999 A
5971855 Ng Oct 1999 A
5971922 Arita et al. Oct 1999 A
5983003 Lection et al. Nov 1999 A
5983217 Khosravi-Sichani et al. Nov 1999 A
5987471 Bodine et al. Nov 1999 A
5995969 Lee et al. Nov 1999 A
5997476 Brown Dec 1999 A
5997502 Reilly et al. Dec 1999 A
6001065 DeVito Dec 1999 A
6022315 Iliff Feb 2000 A
6022615 Rettenbacher Feb 2000 A
6023686 Brown Feb 2000 A
6024281 Shepley Feb 2000 A
6024699 Surwit et al. Feb 2000 A
6029138 Khorasani et al. Feb 2000 A
6032119 Brown et al. Feb 2000 A
6035328 Soukal Mar 2000 A
6046761 Echerer Apr 2000 A
6049794 Jacobs et al. Apr 2000 A
6050940 Braun et al. Apr 2000 A
6055314 Spies et al. Apr 2000 A
6055487 Margery et al. Apr 2000 A
6055506 Frasca, Jr. Apr 2000 A
6057758 Dempsey et al. May 2000 A
6068615 Brown et al. May 2000 A
6101478 Brown Aug 2000 A
6110148 Brown et al. Aug 2000 A
6113578 Brown Sep 2000 A
6138145 Kawanaka Oct 2000 A
6144837 Quy Nov 2000 A
6151586 Brown Nov 2000 A
6161095 Brown Dec 2000 A
6167362 Brown et al. Dec 2000 A
6167386 Brown Dec 2000 A
6168563 Brown Jan 2001 B1
6177940 Bond et al. Jan 2001 B1
6186145 Brown Feb 2001 B1
6189029 Fuerst Feb 2001 B1
D439242 Brown et al. Mar 2001 S
6210272 Brown Apr 2001 B1
6221012 Maschke et al. Apr 2001 B1
6233539 Brown May 2001 B1
6240393 Brown May 2001 B1
6246992 Brown Jun 2001 B1
6248065 Brown Jun 2001 B1
6260022 Brown Jul 2001 B1
6270455 Brown Aug 2001 B1
6270456 Iliff Aug 2001 B1
6334778 Brown Jan 2002 B1
6352523 Brown et al. Mar 2002 B1
6368273 Brown Apr 2002 B1
6370513 Kolawa et al. Apr 2002 B1
6375469 Brown Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6381577 Griffin Apr 2002 B1
6436036 Miller-Kovach et al. Aug 2002 B1
6513532 Mault et al. Feb 2003 B2
20020019748 Brown Feb 2002 A1
20040106855 Brown Jun 2004 A1
20040107116 Brown Jun 2004 A1
20040117207 Brown Jun 2004 A1
20040117208 Brown Jun 2004 A1
20040117209 Brown Jun 2004 A1
20040117210 Brown Jun 2004 A1
Foreign Referenced Citations (36)
Number Date Country
0286456 Oct 1988 EP
0320749 Jun 1989 EP
370599 May 1990 EP
0461910 Dec 1991 EP
508912 Oct 1992 EP
526166 Feb 1993 EP
0558975 Sep 1993 EP
0653718 May 1995 EP
676709 Oct 1995 EP
680727 Nov 1995 EP
761160 Mar 1997 EP
08131551 Dec 1997 EP
0251520 Jan 1998 EP
2218831 Nov 1989 GB
2225637 Jun 1990 GB
54005785 Jan 1979 JP
54146633 Nov 1979 JP
62226278 Oct 1987 JP
5155024 Jun 1993 JP
5266002 Oct 1993 JP
WO-8501667 Apr 1985 WO
WO-9000367 Jan 1990 WO
WO-9109374 Jun 1991 WO
WO-9301489 Jan 1993 WO
WO-9416774 Aug 1994 WO
WO-9509386 Apr 1995 WO
WO-9520199 Jul 1995 WO
WO-9522131 Aug 1995 WO
WO-9529447 Nov 1995 WO
WO-9607908 Mar 1996 WO
WO-9625877 Aug 1996 WO
WO-9636923 Nov 1996 WO
WO-9708605 Mar 1997 WO
WO-9712544 Apr 1997 WO
WO-9737738 Oct 1997 WO
WO-9816895 Apr 1998 WO
Related Publications (1)
Number Date Country
20080046268 A1 Feb 2008 US
Continuations (2)
Number Date Country
Parent 09625080 Jul 2000 US
Child 11835593 US
Parent 09160970 Sep 1998 US
Child 09625080 US